Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -96.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
Business Summary
Number of employees: 191
Sales per Business
USD in Million | 2016 | Weight | 2017 | Weight | Delta |
---|---|---|---|---|---|
Personal Care
97.6
%
| 3 | 75.5 % | 3 | 97.6 % | -8.21% |
Medical Products
2.4
%
| 1 | 24.5 % | 0 | 2.4 % | -93.06% |
Sales per region
USD in Million | 2016 | Weight | 2017 | Weight | Delta |
---|---|---|---|---|---|
North America
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -28.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
Nikole Jessie
IRO | Public Communications Contact | - | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,662,469,227 | 1,645,844,535 ( 99.00 %) | 0 | 99.00 % |
Stock B | 0 | 100,000 | 0 | 0 |
Company contact information
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-96.00% | 166K | |
+98.40% | 6.14B | |
+98.02% | 1.23B | |
+2.57% | 986M | |
+16.68% | 763M | |
+2.01% | 666M | |
+2.33% | 621M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- Company Oncologix Tech, Inc.